Company Number: 12569138

Analysis Date: 2025-07-19 12:25 UTC

Financial Health Assessment for COSY MOOSE LIMITED

---

1. Financial Health Score: D

Explanation:
COSY MOOSE LIMITED demonstrates persistent financial distress characterized by negative net assets and net current liabilities over multiple years. While recent trends show some improvement, the company remains in a vulnerable state with a weak equity base and ongoing liquidity challenges. The "D" grade reflects a financially unstable condition needing urgent corrective action to avoid further deterioration.

---

2. Key Vital Signs (Core Financial Metrics)

Metric	2024 Value (£)	Interpretation
Net Assets (Shareholders' Funds)	-2,023	Negative net assets indicate the company owes more than it owns — a symptom of financial distress.
Net Current Assets (Working Capital)	-18,260	Negative working capital shows short-term liabilities exceed short-term assets, risking cash flow issues.
Cash Position	16,523	Healthy cash on hand relative to prior years; a positive sign but insufficient to cover all liabilities.
Current Liabilities	38,859	Substantial short-term debts that need timely settlement to avoid insolvency risks.
Fixed Assets	16,237	Tangible assets have declined, reflecting depreciation and possible asset sales or underinvestment.
Directors' Loan Accounts	29,071	Significant director loans, indicating reliance on internal financing which may pressure liquidity.
Turnover / Revenue	Not disclosed	Lack of turnover data limits assessment of operational performance and profitability.
Employee Count	4 (down from 6)	Workforce reduction may indicate cost-cutting but can also impact operational capacity.

---

3. Diagnosis: Financial Symptoms and Underlying Business Health

• Liquidity Strain: Chronic negative working capital over five years signals ongoing liquidity stress. The company struggles to cover short-term obligations with current assets, a critical "symptom of distress" risking operational continuity.

• Capital Deficiency: Negative net assets and shareholders' funds reveal that the company’s total liabilities exceed total assets. This "capital anemia" undermines stakeholder confidence and limits borrowing capacity.

• Cash Flow Condition: Although cash holdings improved to £16,523 in 2024, this is still insufficient against nearly £39k in current liabilities. The company appears reliant on directors' loans (£29k), indicating internal funding support is crucial to keep operations afloat.

• Operational Contraction: Reduction in employee numbers from 6 to 4 could reflect attempts to reduce costs amid financial difficulties but may also impair growth prospects.

• Asset Depreciation: Declining fixed assets (from £24.6k in 2020 to £16.2k in 2024) point to asset wear or sales, possibly to manage cash but potentially impacting productive capacity.

• Absence of Profit & Loss Disclosure: Without turnover and profit data, it is challenging to assess profitability, but persistent losses implied by negative reserves (-£2,123 in 2024) suggest ongoing unprofitability.

---

4. Prognosis: Future Financial Outlook

The company’s financial health shows slight improvement compared to previous years (net assets improved from -£7,193 in 2023 to -£2,023 in 2024), suggesting some stabilization efforts. However, the continued negative net current assets and reliance on director loans pose ongoing risks. Without increased profitability, improved cash flow management, or capital injection, the company risks slipping back into deeper financial distress, potentially facing insolvency or forced restructuring.

---

5. Recommendations: Prescriptions for Financial Wellness

• Improve Working Capital Management: Accelerate debtor collections, negotiate extended payment terms with creditors, and optimize inventory levels to reduce negative working capital.

• Boost Revenue and Profitability: Conduct a detailed operational review to identify revenue growth opportunities and cost-saving measures, focusing on sustainable profit generation.

• Reduce Reliance on Director Loans: Explore external financing options or equity injections to replace internal loans, enhancing financial independence and stability.

• Strengthen Cash Flow Forecasting: Implement robust cash flow monitoring to anticipate liquidity shortages early and take preemptive action.

• Consider Restructuring or Refinancing: If losses persist, engage professional advisors to explore restructuring options, including renegotiation of debts or seeking new investment.

• Maintain Compliance and Timely Reporting: Continue timely filing of accounts and returns to avoid penalties and maintain transparency with stakeholders.

---

Medical Analogy Summary

COSY MOOSE LIMITED is currently exhibiting symptoms of financial distress akin to a patient with chronic "capital anemia" and "liquidity dehydration." While recent treatment efforts have slightly improved the "vital signs," the underlying condition requires ongoing, targeted interventions to restore robust financial health and avoid progression to insolvency "organ failure."

---